Mount Sinai Researchers Receive NIH Grant to Study Promising Treatment for Autism Subtype

• By: Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai
• October 1st, 2013
• clinical trials, IGF-1 treatment, neurodevelopmental disorders, NIH funding, Phelan-McDermid syndrome, research, science, SHANK3 mutation, synaptic plasticity
• 1574    0

Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received a grant from the National Institutes of Health (NIH) to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for a subtype of autism called Phelan McDermid Syndrome (PMS). The grant...